{"task_id": "4020bb65c2bfd0be", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 865/905)", "text": "s://www.ncbi.\nnlm.nih.gov/pmc/articles/PMC2094294/\n\n--- Page 871 ---\n857\nReferences\n33 British Thoracic Society. Guidelines for the management of asthma. 2011. http://www.brit-thoracic.\norg.uk/ClinicalInformation/Asthma/AsthmaGuidelines/tabid/83/Default.aspx\n34 Cates CJ, Cates MJ, Lasserson TJ. Regular treatment with formoterol for chronic asthma: seri-\nous adverse events. Cochrane Database Syst Rev 2008; 4:CD006923. http://onlinelibrary.wiley.com/\ndoi/10.1002/14651858.CD006923.pub2/abstract\n35 Anon. Using beta 2-stimulants in asthma. Drug Ther Bull 1997; 35:1\u20134. \n36 NICE. Omalizumab for severe persistent allergic asthma [TA133]. 2007. https://www.nice.org.uk/guid-\nance/TA133\n37 Hensley MJ. Use of inhaled corticosteroids was associated with the development of cataracts. Evid \nBased Med 1998; 3:24. http://ebm.bmj.com/content/3/1/24.full.pdf+html\n38 Anon. Beyond the lungs\u2014a new view of COPD. Lancet 2007; 370:713. http://www.thelancet.com/jour-\nnals/lancet/article/PIIS0140-6736(07)61349-X/abstract\n39 Wouters E. COPD: a chronic and overlooked pulmonary disease. Lancet 2007; 370:715\u201316. http://www.\nthelancet.com/journals/lancet/article/PIIS0140-6736(07)61352-X/abstract\n40 Steiner M, Barton RL, Singh SJ, et al. Nutritional enhancement of exercise performance in chronic \nobstructive pulmonary disease: a randomised controlled trial. Thorax 200358(9):745\u201351. https://www.ncbi.\nnlm.nih.gov/pmc/articles/PMC1746806/\n41 Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. \nCochrane Database Syst Rev 2006; 3:CD001287. http://onlinelibrary.wiley.com/doi/10.1002/14651858.\nCD001287.pub2/abstract\n42 Soriano JB, Lamprecht B, Ram\u00edrez AS, et al. Mortality prediction in chronic obstructive pulmonary \ndisease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient \ndata. Lancet Respir Med 2015; 3(6):443\u201350. http://www.thelancet.com/journals/lanres/article/PIIS2213-\n2600(15)00157-5/abstract\n43 Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011; 364:1093\u2013\n103. http://www.nejm.org/doi/full/10.1056/NEJMoa1008378\n44 Nannini L, Cates CJ, Lasserson TJ, et al. Combined corticosteroid and long-acting beta-agonist in one \ninhaler versus separate components for COPD. Cochrane Database Syst Rev 2007; 4:CD003794. http://\nwww.ncbi.nlm.nih.gov/pubmed/17943798\n45 Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. \nDe\ufb01 nitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med \n1994; 149(3 Pt 1):818\u201324. http://www.atsjournals.org/doi/pdf/10.1164/ajrccm.149.3.7509706\n46 Diaz-Reganon Valverde G, Fern\u00e1ndez Rico R, Iribarren Sarr\u00edas JL, et al. The administration of 20 ppm \nof inhaled nitric oxide produces a faster response than the inhalation of 5 ppm in adult respiratory distress \nsyndrome. Rev Esp Anesthesiol Reanim 2000; 47(2):57\u201362\n47 Afshari A, Brok J, M\u00f8ller AM, et al. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) \nand acute lung injury in children and adults. Cochrane Database Syst Rev 2010; 7:CD002787. http://onlineli-\nbrary.wiley.com/doi/10.1002/14651858.CD002787.pub2/abstract\n48 Lamontagne F, Briel M, Guyatt GH, et al. Corticosteroid therapy for acute lung injury, acute respiratory \ndistress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care 2010; \n25(3):420\u201335. http://www.jccjournal.org/article/S0883-9441(09)00234-2/abstract\n49 Deal EN, Hollands JM, Schramm GE, et al. Role of corticosteroids in the management of acute res-\npiratory distress syndrome. Clin Ther 2008; 30(5):787\u201399. http://www.sciencedirect.com/science/article/pii/\nS0149291808001823\n50 Davies C, Gleeson FV, Davies RJ, et al. BTS guidelines for the management of pleural infection. Thorax \n2003; 58 Suppl 2:ii18\u201328. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1766018/\n51 Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered \nbreathing and hypertension. N Engl J Med 2000; 342:1378\u201384. http://www.nejm.org/doi/full/10.1056/\nNEJM200005113421901\n52 NICE. Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypop-\nnoea syndrome [TA139]. 2008. http://www.nice.org.uk/Guidance/TA139\n53 Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357(21):2153\u201365. http://www.\nnejm.org/doi/full/10.1056/NEJMra071714 \n54 Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society \nin collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. \nThorax 2008; 63(Suppl V):v1\u2013v58. http://thorax.bmj.com/content/63/Suppl_5/v1.long\n55 Gr\u00f6nhagen-Riska C. Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in \nsarcoidosis, other chest or lymph node diseases and healthy persons. Scand J Respir Dis 1979; 60(2):83\u201393\n56 Iannuzzi MC, Sah BP. Sarcoidosis. In: Merk Manual. http://www.merckmanuals.com/professional/pul-\nmonary_disorders/sarcoidosis/sarcoidosis.html\n57 Evans M, Sharma O, LaBree L, et al. Diff erences in clinical \ufb01 ndings between Caucasians and African \nAmericans with biopsy-proven sarcoidosis. Ophthalmology 2007; 114(2):325\u201333. http://www.aaojournal.org/\narticle/S0161-6420(06)00994-8/abstract\n58 Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society \nin collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. \nThorax 2008; 63:v1\u2013v58 http://thorax.bmj.com/content/63/Suppl_5/v1.long\n59 Watanabe N, Tanada S, Sasaki Y. Pulmonary clearance of aerosolized 99mTc-DTPA in sarcoidosis I \npatients. Q J Nucl Med Mol Imaging 2007; 51(1):82\u201390. http://www.minervamedica.it/en/journals/nuclear-\nmed-molecular-imaging/issue.php?cod=R39Y9999N00\n60 Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society \nin collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. \nThorax 2008; 63(Suppl V):v1\u2013v58. http://thorax.bmj.com/content/63/Suppl_5/v1.long\n61 Fisher M, Nathan SD, Hill C, et al. Predicting life expectancy for pirfenidone in idiopathic pulmonary \n\ufb01 brosis. J Manag Care Spec Pharm 2017; 23(3):S17\u2013S24.", "text_length": 6358, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 865/905)", "type": "chunk", "chunk_index": 864, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.676199", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.677288", "status": "complete", "chunks_added": 4}